Stress hyperglycemia ratio as a prognostic indicator for long-term adverse outcomes in heart failure with preserved ejection fraction.
Journal Information
Full Title: Cardiovasc Diabetol
Abbreviation: Cardiovasc Diabetol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Subject Category: Vascular Diseases
Available in Europe PMC: Yes
Available in PMC: Yes
PDF Available: No
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Ethics approval and consent to participateOur study adhered to the principles of the Helsinki Declaration and received approval from the ethical review board of Shanghai Tenth People’s Hospital. All participating individuals in this research provided written informed consent. Consent for publicationNot applicable. Competing interestsThe authors declare no competing interests. Competing interests The authors declare no competing interests."
"Funding This work was supported in part by Chinese National Natural Science Foundation (82170521), Shanghai Natural Science Foundation of China (21ZR1449500), Foundation of Shanghai Municipal Health Commission (202140263), Tibet Natural Science Foundation of China (XZ2022ZR-ZY27(Z), XZ202301ZR0032G), Foundation of Chongming (CKY2021-21, CKY2020-29), Clinical Research Plan of Shanghai Tenth People’s Hospital (YNCR2A001), and Clinical Research Plan of SHDC (SHDC2020CR4065)."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025